(Q43558683)

24 November 2017

Intermittent, luteal phase nefazodone treatment of premenstrual dysphoric disorder (English)

1 reference

24 November 2017

A Kodesh

1

1 reference

24 November 2017

S Katz

2

1 reference

24 November 2017

A G Lerner

3

1 reference

24 November 2017

B Finkel

4

1 reference

24 November 2017

M Sigal

5

1 reference

24 November 2017

language of work or name

English

0 references

publication date

1 March 2001

1 reference

Journal of Psychopharmacology

24 November 2017

1 reference

24 November 2017

15

1 reference

24 November 2017

1

1 reference

24 November 2017

58-60

1 reference

Nefazodone. A review of its pharmacology and clinical efficacy in the management of major depression

24 November 2017

1 reference

https://api.crossref.org/works/10.1177%2F026988110101500110

Perimenstrual symptoms: prevalence and risk factors

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F026988110101500110

The epidemiology of premenstrual symptoms in a population-based sample of 2650 urban women: attributable risk and risk factors

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F026988110101500110

Tryptophan and neutral amino acids in premenstrual syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F026988110101500110

Imipramine receptor binding and serotonin uptake in platelets of women with premenstrual changes

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F026988110101500110

Estrogen-serotonin interactions: implications for affective regulation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F026988110101500110

Fluoxetine in the treatment of premenstrual dysphoria. Canadian Fluoxetine/Premenstrual Dysphoria Collaborative Study Group.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F026988110101500110

A placebo-controlled clinical trial of L-tryptophan in premenstrual dysphoria.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F026988110101500110

Clomipramine administered during the luteal phase reduces the symptoms of premenstrual syndrome: a placebo-controlled trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F026988110101500110

Prevalence of menstrual cycle symptom cyclicity and premenstrual dysphoric disorder in a random sample of women using and not using oral contraceptives

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F026988110101500110

Paroxetine as a treatment for premenstrual dysphoric disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F026988110101500110

Symptomatic improvement of premenstrual dysphoric disorder with sertraline treatment. A randomized controlled trial. Sertraline Premenstrual Dysphoric Collaborative Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F026988110101500110

10.1177/026988110101500110

21 January 2018

Identifiers

DOI

1 reference

release_ch2oiron55ddrdburerts2q5y4

24 November 2017

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/ch2oiron55ddrdburerts2q5y4

mapped directly with Wikidata item

24 November 2022

based on heuristic

1 reference